This is a standard initial ownership filing for a new officer. No trading activity or change in economic exposure. Monitor future Form 4 filings for any open-market purchases or sales by the CFO.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $14.89entry
- T+1 · 6d ago −12.42%α −11.95% · $13.04
- T+5 · due 11h ago Pending
- T+5 · todayOpen
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Dalen Meeter, Chief Financial Officer of Aspen Neuroscience, filed a Form 3 initial statement of beneficial ownership, disclosing stock options to acquire 224,141 shares of common stock. The filing is a routine insider onboarding requirement with no trading activity or material financial impact.
Key Facts
- Dalen Meeter was appointed Chief Financial Officer of Aspen Neuroscience, Inc.
- Form 3 filed on 2026-10-29 as an initial statement of beneficial ownership.
- Meeter holds three stock option grants: one at $8.70 strike for 101,193 shares (granted March 2025) and two at $5.74 strike for 34,405 and 88,543 shares (granted November 2025).
- Total options disclosed: 224,141 shares of common stock.
- No direct or indirect ownership of common stock was reported; all holdings are derivative securities.
Financial Impact
No financial impact; filing discloses only option holdings with no transaction or monetary consideration.
Risk Factors
- No material risks identified from this filing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-438940 |
| Document: 0001193125-26-438940-index-headers.html | 0001193125-26-438940 |
| Document: 0001193125-26-438940-index.html | 0001193125-26-438940 |
| Document: 0001193125-26-438940.txt | 0001193125-26-438940 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 2d ago | SC 13G | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 3d ago | 8-K | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Oct 30, 2026 6d ago | 424B4 | $13.04 $12.29 | ▼ −5.75% | ▼ −6.05% | $11.76 (−9.82%) |
Oct 30, 2026 6d ago | EFFECT | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | Press Release | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers